Epilepsy

Bio Roundup: Clinical Trials Paused, New MS Drug, Kallyope's Cash & More

Bio Roundup: Clinical Trials Paused, New MS Drug, Kallyope's Cash & More

3 days ago   |   Xconomy   |   2 articles

Finding and enrolling patients for clinical trials is always challenging. The coronavirus pandemic has made it nearly impossible. Fallout from the spread of COVID-19 infections...
Read more ...

Redpin bags A round to advance Chantix-controlled gene therapies

5 days ago   |   Fierce Biotech

Redpin Therapeutics has raised $15.5 million to bankroll chemogenetic R&D. The initial close of the series A positions Redpin to move a controllable gene therapy for the...
Read more ...

Magnolia bark compound could someday help treat drug-resistant epilepsy

10 days ago   |   ScienceDaily

In patients with epilepsy, normal neurological activity becomes disrupted, causing debilitating seizures. Now, researchers report that they have found a potential new treatment...
Read more ...

LncRNA UCA1 Suppresses the Inflammation Via Modulating miR-203-Mediated Regulation of MEF2C/NF-κB Signaling Pathway in Epilepsy

12 days ago   |   Springer

Abstract Although many advances have been made in the pathogenesis of epilepsy recently, the pathological mechanisms of epilepsy are still largely unknown. Exploring the...
Read more ...

A bioanalytical UHPLC based method used for the quantification of Thymoquinone-loaded-PLGA-nanoparticles in the treatment of epilepsy

1 month ago   |   Chemistry Central

To formulate a nanoformulation and to improve brain bioavailability for thymoquinone through intranasal drug delivery, using a newly UHPLC-PDA developed the method and...
Read more ...

Bio Roundup: EQRx's Ambitions, Nektar No Vote, New Frazier Fund & More

Bio Roundup: EQRx's Ambitions, Nektar No Vote, New Frazier Fund & More

2 monthes ago   |   Xconomy

Perhaps the most talked-about news at the JP Morgan Healthcare Conference this week was a new startup that launched with $200 million and an ambitious claim its first drug...
Read more ...

Neurocrine, in Second Epilepsy Deal, Pairs With Swiss Biotech Idorsia

Neurocrine, in Second Epilepsy Deal, Pairs With Swiss Biotech Idorsia

2 monthes ago   |   Xconomy

Neurocrine is doubling down on epilepsy, striking its second agreement in as many months with a new deal that grants it the option to license an investigational treatment for a...
Read more ...

Behind the Seizure® Program Further Expands Access to Genetic Testing for Children to Speed the Diagnosis of Genetic Epilepsy

2 monthes ago   |   San Diego Biotechnology

Biogen, Encoded Therapeutics, Neurogene, Praxis Precision Medicines and PTC Therapeutics join founders BioMarin and Invitae to expand access for children under eight...
Read more ...

A novel IRF2BPL truncating variant is associated with endolysosomal storage

3 monthes ago   |   Springer

Abstract De novo mutations in the IRF2BPL gene have been identified to date in 18 patients presenting with neuromotor regression, epilepsy and variable neurological signs...
Read more ...

Customized multigene panels in epilepsy: the best things come in small packages

3 monthes ago   |   Springer

Abstract Over the past 10 years, the increasingly important role played by next-generation sequencing panels in the genetic diagnosis of epilepsy has led to a growing list of...
Read more ...


Register you to post on BioTech Mag

Free Registration

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Mirati Therapeutics: Vice President, Investor Relations & External Affairs...

Mirati Therapeutics: The Vice President, Investor Relations and External Affairs will be responsible for the development, implementation and management of an... San Diego, CA... Read more ...

16S rRNA Gene-Based Analysis Reveals the Effects of Gestational Diabetes on...

Abstract Hyperglycemia is one of the metabolic characteristics of gestational diabetes mellitus. Considering that GDM is able to cause changes in the gut bacterial community... Read more ...

New gene therapy product Zolgensma to treat spinal muscular atrophy

Posted on: 30 March 2020, The EMA has recommended granting a conditional marketing authorisation in the European Union for the gene therapy Zolgensmato treat babies and young... Read more ...

Modeling ethanol production through gas fermentation: a biothermodynamics...

Ethanol production through fermentation of gas mixtures containing CO, CO2 and H2 has just started operating at commercial scale. However, quantitative schemes for... Read more ...

Use of pretreatments for enhancing clarification efficiency of depth...

ABSTRACT High cell density, high product titer mammalian cell culture is the new paradigm for production of recombinant proteins. While the typical motivation is to get a high... Read more ...

Rigel Pharmaceuticals, Inc.: Territory Business Manager

Rigel Pharmaceuticals, Inc.: - This is a field based position covering San Diego, South Eastern portion of California and Las Vegas POSITION SUMMARY: Rigel Territory... Read more ...

AveXis Inc.: Research and Development Professionals

AveXis Inc.: OverviewWe're Growing and looking for talented Research professionals!Ready to join a team committed to moving gene therapies into the clinical and co San Diego... Read more ...

Mirati Therapeutics: Quality Assurance Contractor: 2020-64

Mirati Therapeutics: Mirati is looking for a Quality Assurance Contractor to join its Quality team. The ideal candidate will have prior experience working in a fast -paced San... Read more ...

Bachem: Chemist I

Bachem: Your Responsibilities Note: This position is only for 2nd shift The Chemist function is to develop the peptide manufacture process, manufactur Vista, CA, US ... Read more ...

Bachem: Materials Coordinator I

Bachem: Your Responsibilities The Materials Coordinator handles and controls raw materials including dispensing and sampling operations. Responsible for the s Vista, CA, US ... Read more ...